Biopharma week in review
Clinical Trial Results Alnylam Pharmaceuticals reported positive Phase 3 results for vutrisiran in treating transthyretin amyloidosis cardiomyopathy, boosting the company’s […]
Source
Clinical Trial Results Alnylam Pharmaceuticals reported positive Phase 3 results for vutrisiran in treating transthyretin amyloidosis cardiomyopathy, boosting the company’s […]
Source
17th Edition Project Portfolio and Resource Management Excellence for Pharma July 11-13, 2023 | Sheraton Philadelphia University City Hotel | Philadelphia, PA Mastering Resource and Project Prioritization, Operational Excellence, and People Developmen…
17th Edition Project Portfolio and Resource Management Excellence for Pharma Read Post »
DrugPatentWatch publisher Yali Friedman, Ph.D. will be speaking at the 15th Edition Pharma Resource Planning and Portfolio Optimization Conference. The event is from from April 25-26, 2022 at the Sheraton…
The post Join DrugPatentWatch at the 15th Phar…
DrugPatentWatch has been ranked the “Best Biopharmaceuticals Commercial Business Intelligence Platform” by Global Health & Pharma News This award is dedicated to honoring the innovation, determination and outstanding levels of…
The post DrugPatentWatch…
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform Read Post »
Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and…
The post Updating the DrugPatentWatch Biologics Module appeared…
This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference. I discuss: Identifying generic entry opportunities at the earliest stages Discovering opportunities that avoid litigation…
The post Generic Portfolio Manage…
Generic Portfolio Management, Partnering with Brands, and Staying Competitive Read Post »
I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…
The post Workshop and lecture on generic portfolio management appe…
Workshop and lecture on generic portfolio management Read Post »
I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…
The post Upcoming workshop on generic portfolio management appeare…
Upcoming workshop on generic portfolio management Read Post »
Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. We’ll be sharing our expertise and best practices for strategic…
The post DrugPatentWatch and Abbvie discuss Pharma…
DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management Read Post »
New DrugPatentWatch module connects excipients and drug patents In response to user requests, DrugPatentWatch has added a new database of excipients (inactive ingredients) in drugs, and integrated it with our…
The post Connecting Excipients with Drug P…
Connecting Excipients with Drug Patents – New DrugPatentWatch module Read Post »